Papers
38
Total Citations
2,110
H-Index
19
About
Dipen J. Parekh is a pioneering urologic oncologist whose career has been defined by a relentless pursuit of surgical innovation in the treatment of bladder cancer and urological malignancies. He is best known as the principal investigator of the landmark RAZOR trial — a phase 3, randomized, non-inferiority study comparing robot-assisted and open radical cystectomy — which has amassed over 760 citations since its 2018 publication and fundamentally shaped how surgeons approach bladder cancer treatment worldwide. His early pilot randomized trial (2012, 283 citations) was among the first prospective studies to rigorously evaluate robotic cystectomy, countering the limitations of prior retrospective analyses. Parekh has further enriched the field through systematic reviews and meta-analyses consolidating evidence across randomized controlled trials, extended three-year follow-up data from the RAZOR cohort, and quality-of-life assessments that place patient experience at the center of surgical decision-making. Beyond cystectomy, his contributions span robotic nephroureterectomy, partial nephrectomy utilization trends, and urinary reconstruction in high-risk patients. With collectively over 1,500 citations across his most impactful works, Parekh stands as a transformative figure in evidence-based minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10